Category: Peptide Basics

Foundational explainers on peptides for research.

  • Longevity Research Peptides: Epitalon, MOTS-c and the Category Explained

    The “longevity peptide” category, explained

    A recurring grouping in the research-peptide market is the longevity peptides — a set of compounds studied in the biology of cellular ageing and metabolism. The two most prominent are Epitalon and MOTS-c. This overview explains what the category actually is as a set of research materials, why these two peptides are grouped together despite very different origins, and what a research buyer should check when sourcing them.

    Everything here concerns these peptides as research materials only. The peptides Solis supplies are for laboratory research use only — not for human or veterinary use, and not a medicine, supplement, or cosmetic. Nothing below is medical, dosing, or usage guidance. For the fundamentals, see our primer on what peptides are.

    What ties the category together

    The “longevity” label groups peptides by the research questions they are studied within — cellular ageing, telomere biology, mitochondrial and metabolic function — rather than by a shared structure or receptor. That is why two structurally unrelated peptides sit side by side here:

    • They are studied in ageing-biology and metabolic research models.
    • They are not approved medicines, and are handled as research chemicals.
    • Their marketing tends to lean on the “longevity” framing, which makes careful, claim-free documentation especially important.

    It is a category defined by research theme, not by chemistry — a distinction worth holding onto when comparing products.

    Epitalon and MOTS-c

    • Epitalon. A synthetic tetrapeptide (Ala-Glu-Asp-Gly) associated with the pineal gland, studied chiefly around telomerase and circadian biology in research models.
    • MOTS-c. A mitochondrial-derived peptide encoded in mitochondrial DNA, studied mainly around metabolic regulation and the AMPK pathway.

    Their origins could hardly be more different — one a short pineal-associated sequence, the other encoded in the mitochondrial genome — but both are studied in the broad biology of ageing and metabolism, which is what places them in the same commercial category.

    Mechanisms explored in the literature

    • Telomere biology (Epitalon). Studied for its reported association with telomerase, the enzyme that maintains telomeres — a marker in cellular-ageing research.
    • Metabolic and mitochondrial signalling (MOTS-c). Studied in relation to the AMPK energy-sensing pathway and metabolic homeostasis in research models.

    As always, these are mechanisms examined in preclinical research, not approved clinical outcomes. Neither is an approved therapeutic.

    Quality considerations when sourcing longevity peptides

    Both are short and relatively inexpensive to synthesise, which means the market carries a wide quality range. The documentation that separates credible material from an unknown powder is the standard set:

    • Identity (mass spectrometry) confirming the specific sequence for the lot.
    • HPLC purity of ≥98%, shown as an actual chromatogram.
    • A lot-specific Certificate of Analysis, plus clarity on net peptide content.

    We document our analytics on the Quality & Analytics page, and current formats are in the catalogue.

    Frequently asked questions

    What are longevity peptides?

    It is a market grouping for research peptides studied in ageing and metabolic biology — chiefly Epitalon and MOTS-c. The label describes a research theme, not a shared chemical class.

    Why are Epitalon and MOTS-c grouped together?

    Because both are studied within ageing and metabolic research, even though they are structurally unrelated — Epitalon is a pineal-associated tetrapeptide, MOTS-c is a mitochondrial-derived peptide.

    Are longevity peptides approved drugs?

    No. They are handled as research materials for laboratory use only, not approved medicines.

    What should I check when sourcing them?

    Mass-spec identity, ≥98% HPLC purity with a chromatogram, and a lot-specific CoA — the same rigorous checklist that applies to any research peptide.

    In summary

    The longevity-peptide category groups research compounds by theme — the biology of ageing and metabolism — rather than by chemistry, which is how structurally unrelated peptides like Epitalon and MOTS-c end up side by side. As with any research peptide, documentation is what separates products: ≥98% HPLC purity, mass-spec identity, and a lot-specific CoA. See the Quality & Analytics page or browse the catalogue.


    Solis Peptides supplies research peptides for laboratory research use only — not for human or veterinary use, and not a medicine, supplement, or cosmetic. Nothing in this article is medical, dosing, or usage advice.

  • Nootropic Peptides: Semax, Selank and the Regulatory-Peptide Category

    The nootropic peptide category, explained

    Among research peptides, a distinct cluster is grouped under the informal label “nootropic peptides” — short, regulatory sequences studied in neuroscience research models. The two most prominent are Semax and Selank, both originating from Russian peptide research. This overview explains what this category is as a set of research materials, how Semax and Selank relate, and what a research buyer should check when sourcing them.

    Everything here concerns these peptides as research materials only. The peptides Solis supplies are for laboratory research use only — not for human or veterinary use, and not a medicine, supplement, or cosmetic. Nothing below is medical, dosing, or usage guidance. For the fundamentals, see our primer on what peptides are.

    What defines a “nootropic” research peptide

    Unlike the growth-hormone or repair peptides, this group is defined by where it is studied — neuroscience and behavioural research models — rather than by a shared receptor. Both Semax and Selank are:

    • Short regulatory peptides derived from larger endogenous sequences.
    • Studied in central-nervous-system research contexts, which is why the informal “nootropic” grouping stuck.
    • Not approved medicines in the major Western regulatory jurisdictions, and handled as research chemicals.

    The label is a category of convenience, not a pharmacological class — a point worth keeping in mind when reading marketing that treats them as interchangeable.

    Semax and Selank

    • Semax. A peptide derived from a fragment of adrenocorticotropic hormone (ACTH), studied in neuroscience research models. It is the more widely referenced of the two in the “nootropic” grouping.
    • Selank. A synthetic analogue based on the endogenous peptide tuftsin, studied in research contexts around regulatory-peptide biology.

    The two are frequently listed side by side and sometimes studied together, but they derive from different parent sequences — Semax from ACTH, Selank from tuftsin — and should be documented as the distinct compounds they are.

    Mechanisms explored in the literature

    Because these are grouped by research area rather than a single mechanism, the literature is correspondingly varied:

    • Regulatory-peptide signalling. Both are studied as short regulatory peptides that interact with neuropeptide systems in research models.
    • Stability variants. Some listings offer N-acetylated or otherwise modified variants intended to alter stability — a detail that should be reflected in the product name and analytics.

    As always, these are mechanisms and observations from research models, not approved clinical outcomes. Neither is an approved therapeutic in the major Western regulators.

    Quality considerations when sourcing nootropic peptides

    The sourcing checklist is the standard one, with attention to which exact variant is being sold:

    • Identity (mass spectrometry) confirming the specific sequence and any modification (e.g. acetylation) for the lot.
    • HPLC purity of ≥98%, shown as an actual chromatogram.
    • A lot-specific Certificate of Analysis, plus clarity on net peptide content.

    We document our analytics on the Quality & Analytics page, and current formats are in the catalogue.

    Frequently asked questions

    What are nootropic peptides?

    It is an informal grouping for short regulatory research peptides — chiefly Semax and Selank — studied in neuroscience research models. The label describes a research area, not a single pharmacological class.

    How are Semax and Selank different?

    They derive from different parent sequences: Semax from a fragment of ACTH, Selank from the peptide tuftsin. They are distinct compounds often listed together.

    Are Semax and Selank approved drugs?

    Not in the major Western regulatory jurisdictions. They are handled as research materials for laboratory use only.

    What should I check when sourcing them?

    Mass-spec identity (including any acetylation or modification), ≥98% HPLC purity with a chromatogram, and a lot-specific CoA.

    In summary

    The “nootropic peptide” category is a grouping of convenience for short regulatory research peptides, led by Semax and Selank. They share a research area, not a mechanism, and derive from different parent sequences. As with any research peptide, documentation is what separates products: ≥98% HPLC purity, mass-spec identity, and a lot-specific CoA. See the Quality & Analytics page or browse the catalogue.


    Solis Peptides supplies research peptides for laboratory research use only — not for human or veterinary use, and not a medicine, supplement, or cosmetic. Nothing in this article is medical, dosing, or usage advice.

  • The Copper Peptide Family: GHK-Cu and Its Relatives — A Research Overview

    The copper peptide family, at a glance

    Copper peptides are a small but distinctive group of research peptides defined by one shared feature: they bind a copper ion. The best known is GHK-Cu — the tripeptide glycyl-L-histidyl-L-lysine complexed with copper(II). This overview explains what copper peptides are as research materials, why the copper matters, how the family is grouped, and what a research buyer should check when sourcing them.

    Everything here concerns these peptides as research materials only. The peptides Solis supplies are for laboratory research use only — not for human or veterinary use, and not a medicine, supplement, or cosmetic. Nothing below is medical, dosing, or usage guidance. For the fundamentals of how peptides are defined, see our primer on what peptides are.

    What makes a peptide a “copper peptide”

    The defining feature is a copper-binding motif. In GHK, the histidine residue and the peptide backbone form a site that coordinates a copper(II) ion, producing the blue-tinted GHK-Cu complex. This peptide-copper coordination is the whole reason the family is studied as a distinct group rather than as ordinary short peptides.

    Two labelling points a research buyer runs into:

    • GHK vs GHK-Cu. “GHK” is the bare tripeptide; “GHK-Cu” is the copper complex. They are chemically different materials, and a Certificate of Analysis should make clear which one a vial contains.
    • Copper content. Because the copper is part of the complex, the analytics for GHK-Cu differ from a plain peptide — the ratio and identity of the copper complex matter, not just peptide purity.

    Members of the family

    Across research-peptide suppliers, the copper-peptide category is small and centres on:

    • GHK-Cu. The flagship copper tripeptide, by far the most studied and most widely listed.
    • Related copper-binding sequences. A handful of longer copper-binding peptides appear in the literature, but GHK-Cu dominates the commercial category.

    Because the family is so GHK-centred, most sourcing questions in practice are really questions about GHK-Cu specifically — which our dedicated GHK-Cu profile covers in depth.

    Mechanisms explored in the literature

    Copper peptides are studied chiefly in the context of copper delivery and matrix biology in research models:

    • Copper as a cofactor. Copper is a cofactor for a number of enzymes, and GHK-Cu is studied as a way of presenting copper in a peptide-bound form in experimental systems.
    • Extracellular-matrix research. GHK and GHK-Cu appear in research literature on tissue and matrix remodelling models.

    As always, these are mechanisms examined in research, not approved clinical outcomes. Copper peptides are not approved therapeutics.

    Quality considerations when sourcing copper peptides

    For a research buyer, copper peptides carry one extra layer beyond the usual checks, because the metal complex is part of the product:

    • Identity (mass spectrometry) confirming the peptide sequence for the lot.
    • HPLC purity of ≥98% for the peptide component, shown as a real chromatogram.
    • Copper-complex clarity — whether the material is the copper complex (GHK-Cu) or the free peptide (GHK), documented on the Certificate of Analysis.

    We document our analytics on the Quality & Analytics page, and current copper-peptide formats are in the catalogue.

    Frequently asked questions

    What are copper peptides?

    Copper peptides are short peptides that bind a copper ion, the best-known being GHK-Cu (the tripeptide GHK complexed with copper). In research they are studied as copper-carrying peptide complexes.

    What is the difference between GHK and GHK-Cu?

    GHK is the bare tripeptide; GHK-Cu is the same peptide coordinated to a copper(II) ion. They are distinct materials, and a CoA should specify which one is in the vial.

    Are copper peptides approved drugs?

    No. Copper peptides are handled as research materials for laboratory use only, not as approved medicines.

    What should I check when sourcing a copper peptide?

    Mass-spec identity, ≥98% HPLC purity for the peptide, and clear documentation of whether the material is the copper complex or the free peptide — all on a lot-specific CoA.

    In summary

    Copper peptides are a compact research category defined by copper binding, with GHK-Cu as the flagship. The extra sourcing consideration versus an ordinary peptide is the copper complex itself, which the documentation should spell out. As with any research peptide, what separates products is evidence: ≥98% HPLC purity, mass-spec identity, and a lot-specific CoA. See the Quality & Analytics page or browse the catalogue.


    Solis Peptides supplies research peptides for laboratory research use only — not for human or veterinary use, and not a medicine, supplement, or cosmetic. Nothing in this article is medical, dosing, or usage advice.

  • Growth-Hormone Secretagogues Explained (for Research)

    “Growth-hormone secretagogue” is one of the most common phrases in the research-peptide world, and one of the most useful to actually understand. It is the umbrella term for a whole family of peptides — CJC-1295, Sermorelin, Tesamorelin, Ipamorelin and others — that are studied for their interaction with the growth-hormone axis. This primer explains what the term means, the two mechanistic families inside it, and why they are so often studied together.

    This concerns these peptides strictly as research materials. The peptides Solis supplies are for laboratory research use only — not for human or veterinary use — and nothing here is medical, dosing, or usage guidance.

    What “secretagogue” means

    A secretagogue is simply something that stimulates secretion. A growth-hormone secretagogue is a compound studied for its ability to prompt the release of growth hormone from the pituitary in research models. Crucially, these peptides are studied for engaging the body’s own signalling systems — not for being growth hormone themselves.

    The two families

    Almost every research growth-hormone secretagogue falls into one of two mechanistic families, defined by which receptor it engages:

    • GHRH analogues. These mimic growth-hormone-releasing hormone and act on the GHRH receptor. The group includes Sermorelin, CJC-1295, and Tesamorelin — they differ mainly in how they are stabilised.
    • Ghrelin mimetics (GHRPs). These mimic ghrelin and act on the GHS-R1a (ghrelin) receptor. The best-known example is Ipamorelin, noted in the literature for its selectivity.

    Understanding this split is the single most useful concept in the category: it explains why some peptides are grouped together and others are treated as complementary.

    Why they’re studied in pairs

    Because the two families reach the same axis through different receptors, they are frequently studied as a pair — for example a GHRH analogue alongside a ghrelin mimetic. The logic in the research literature is that engaging two separate routes into the growth-hormone axis is mechanistically distinct from engaging one twice. This is why catalogues so often list CJC-1295 and Ipamorelin together.

    What to check when sourcing

    Whichever family a secretagogue belongs to, the documentation that matters is the same: ≥98% HPLC purity (with the chromatogram), mass-spectrometry identity, and a lot-specific Certificate of Analysis. We document all of this on our Quality & Analytics page.

    Frequently asked questions

    What is a growth-hormone secretagogue?

    A compound studied for stimulating the release of growth hormone from the pituitary in research models, by engaging the body’s own signalling receptors rather than being growth hormone itself.

    What are the two families?

    GHRH analogues (acting on the GHRH receptor — e.g. Sermorelin, CJC-1295, Tesamorelin) and ghrelin mimetics or GHRPs (acting on the ghrelin receptor — e.g. Ipamorelin).

    Why are GHRH analogues and GHRPs studied together?

    Because they reach the growth-hormone axis through two different receptors, so they are mechanistically complementary rather than redundant.

    In summary

    Growth-hormone secretagogues are a family of research peptides split into two mechanistic groups — GHRH analogues and ghrelin mimetics — that engage the growth-hormone axis through different receptors, which is why they are so often studied in pairs. See the individual profiles for CJC-1295, Sermorelin, Tesamorelin and Ipamorelin, or browse the catalogue.


    Solis Peptides supplies research peptides for laboratory research use only — not for human or veterinary use, and not a medicine, supplement, or cosmetic. Nothing in this article is medical, dosing, or usage advice.

  • What Are Peptides? A Clear, Practical Guide for Research

    Peptides sit at the centre of a huge amount of modern life-science research — and yet, for anyone coming to the field for the first time, the word itself can be confusing. Are peptides the same as proteins? Are they drugs? Supplements? Chemicals? The honest answer is that a peptide is a very specific kind of molecule, and once you understand what it is and how it behaves, the rest of the landscape becomes much easier to navigate.

    This guide explains what peptides are, how they differ from proteins, how they are made, and how they work at a molecular level. It is written for people evaluating research peptides — laboratory researchers, procurement teams, and distributors — rather than for any personal or clinical purpose. Everything here relates to peptides as research materials. The peptides Solis supplies are sold strictly for laboratory research use only, not for human or veterinary use, and nothing in this article is medical, dosing, or usage guidance.

    What is a peptide?

    A peptide is a short chain of amino acids linked together in a defined sequence. Amino acids are the small organic building blocks that living systems use to assemble almost everything functional inside a cell. There are twenty standard amino acids, and the specific order in which they are strung together determines what the resulting molecule is and how it behaves.

    The link between one amino acid and the next is called a peptide bond — a chemical bond formed when the carboxyl group of one amino acid joins the amino group of the next, releasing a molecule of water. Chain enough amino acids together through these bonds and you have a peptide. Two amino acids make a dipeptide, three a tripeptide, and a longer run a polypeptide.

    Because the sequence is so precise, even a single amino acid substitution can change a peptide’s shape, stability, and behaviour. This is exactly why sequence fidelity and purity matter so much when peptides are used as research reagents: the molecule you think you are studying and the molecule actually in the vial need to be the same thing.

    Peptides vs. proteins: where is the line?

    Peptides and proteins are made from the same raw materials — amino acids joined by peptide bonds — so where does one end and the other begin? The distinction is mostly about size and structure. By convention, a chain of roughly 50 amino acids or fewer is called a peptide, while longer chains that fold into stable three-dimensional shapes are called proteins. The cut-off is a convention rather than a hard law of chemistry, which is why borderline molecules get described either way. Insulin, for instance, has 51 amino acids and is often called a small protein.

    The more useful difference is functional. Proteins typically fold into elaborate, stable structures that let them act as enzymes, scaffolds, or molecular machines. Peptides are generally smaller and more flexible, and many work as signalling molecules — short messages that fit a specific receptor and tell a cell to do something.

    How peptides are made

    There are two broad routes by which peptides come into existence: the body makes them, or a laboratory synthesises them.

    In living systems (endogenous peptides). Cells build peptides using the same machinery that builds proteins, translating genetic information into precise sequences, then cutting and modifying the results. Many well-known molecules are peptides in this sense — oxytocin, vasopressin, glucagon, and a range of hormone-releasing and hormone-inhibiting factors.

    In the laboratory (synthetic peptides). Research peptides are manufactured chemically, most often by solid-phase peptide synthesis (SPPS), in which the peptide is built one amino acid at a time on a solid resin support, each residue added, coupled, and deprotected in a tightly controlled cycle. Once assembled, the peptide is cleaved from the resin and purified.

    The purification and verification steps are where quality is won or lost. Crude synthetic peptide always contains some truncated or side-product molecules, so it is purified — typically by reverse-phase high-performance liquid chromatography (RP-HPLC) — and its identity confirmed by mass spectrometry. A credible research peptide is characterised by a stated HPLC purity (commonly ≥98% for research-grade material) and a batch Certificate of Analysis (CoA). You can read how we handle this on our Quality & Analytics page.

    How peptides work at a molecular level

    Because peptides come in so many sequences, they do not all work the same way. But most peptides that attract research attention fall into a few functional patterns.

    Signalling peptides. The largest and most studied category. A signalling peptide has a shape that fits a specific receptor — often on the surface of a cell. When it binds, it triggers a cascade inside the cell, like a key turning a lock. Peptide hormones work this way: the peptide is the message, the receptor is the mailbox, and the cell’s internal machinery acts on the message.

    Carrier peptides. Some peptides bind and transport other molecules. A frequently cited example is the copper-binding tripeptide GHK-Cu, studied precisely because it carries a copper ion.

    Enzyme-modulating peptides. Others act on enzymes — inhibiting or influencing their activity — which makes them valuable tools for probing biochemical pathways in a controlled way.

    Across all of these, a recurring theme is specificity. Peptides tend to interact with defined targets rather than acting broadly, which is exactly what makes them attractive research tools.

    The main categories of research peptides

    If you browse a research-peptide catalogue, the entries usually cluster into a few families:

    • Growth-hormone secretagogues and releasing factors — peptides studied around the growth-hormone axis, including GHRH analogues and ghrelin-receptor research peptides (e.g. sermorelin, tesamorelin, CJC-1295, ipamorelin).
    • Regenerative and repair-research peptides — investigated in tissue and cellular research contexts (e.g. BPC-157, TB-500).
    • Copper and cosmetic-research peptides — carrier peptides such as GHK-Cu.
    • Neuropeptides and cognition-research peptides — examined in neurological and behavioural research models (e.g. Semax, Selank).
    • Longevity and metabolic-research peptides — sequences studied in ageing and metabolic pathways (e.g. Epitalon, MOTS-c).

    Each has its own literature, mechanisms of interest, and market. We publish a dedicated profile for each peptide we carry — see the full range in our catalogue.

    Why peptides matter in research

    Peptides occupy a valuable middle ground: large and specific enough to interact with precise biological targets, but small and well-defined enough to be synthesised chemically, purified to a known standard, and characterised exactly. That combination is unusual, and it is why peptides have become such important tools across biochemistry, cell biology, pharmacology research, and materials science.

    Three properties stand out. Peptides are modular — change one amino acid and study the effect. They are specific — a given sequence tends to engage a defined target. And they are reproducible when made well — a properly synthesised, purified, and documented peptide can be the same from batch to batch, which is the foundation of any experiment others are expected to repeat. A research peptide is only as useful as its documentation: two vials with the same label but different real purities are, for research purposes, two different materials.

    What “Research Use Only” actually means

    You will see the phrase Research Use Only (RUO) on legitimate research-peptide products, including everything Solis supplies. It is not marketing boilerplate — it defines what the material is sold for and how it may lawfully be handled.

    Research Use Only means the product is intended for laboratory research and experimental purposes only. It is not a medicine, supplement, or cosmetic, and not intended for human or veterinary use. It has not been evaluated or approved as a therapeutic product, and it should be handled only by, or under the supervision of, qualified individuals in an appropriate research environment, in line with all applicable local regulations. The RUO framing is also what keeps the product in the correct regulatory lane — the research-chemical lane — which is why responsible vendors describe mechanisms studied in the literature rather than making health, benefit, or dosing claims. Read more on our About Solis Peptides page.

    Frequently asked questions

    Is a peptide the same as a protein?

    Not quite. Both are chains of amino acids joined by peptide bonds, but peptides are shorter — by convention around 50 amino acids or fewer — and generally more flexible, while proteins are longer chains that fold into stable three-dimensional structures.

    How are research peptides made?

    Most are produced by solid-phase peptide synthesis, in which the sequence is assembled one amino acid at a time on a solid support, then purified (usually by reverse-phase HPLC) and confirmed by mass spectrometry.

    What does ≥98% HPLC purity mean?

    It means that when the material is analysed by high-performance liquid chromatography, at least 98% of the detected content corresponds to the target peptide, with impurities making up the remainder. Research-grade material is typically characterised at this level, with a batch Certificate of Analysis to document it.

    What does “Research Use Only” mean?

    It means the product is intended solely for laboratory research and is not for human or veterinary use, not a medicine, supplement, or cosmetic, and has not been approved as a therapeutic. It should be handled only in an appropriate research setting by qualified people.

    In summary

    A peptide is a short, precisely sequenced chain of amino acids linked by peptide bonds — smaller than a protein, often flexible, and frequently acting as a specific biological signal. Research peptides are synthesised chemically, purified to a documented standard, and characterised by sequence, purity, and Certificate of Analysis. Handled correctly and sold on the correct Research Use Only basis, they are among the most versatile and reproducible tools available to modern life-science research. If you are evaluating research peptides, the two things worth checking first are always the same: the purity and the paperwork behind it. See how Solis documents both on our Quality & Analytics page, or browse the full range in our catalogue.


    Solis Peptides supplies research peptides for laboratory research use only — not for human or veterinary use, and not a medicine, supplement, or cosmetic. Nothing in this article is medical, dosing, or usage advice.